Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA). (Q37465550)
Jump to navigation
Jump to search
scientific article published on 13 August 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA). |
scientific article published on 13 August 2013 |
Statements
1 reference
Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA). (English)
1 reference
P J Mease
1 reference
R Fleischmann
1 reference
A A Deodhar
1 reference
J Wollenhaupt
1 reference
M Khraishi
1 reference
D Kielar
1 reference
F Woltering
1 reference
C Stach
1 reference
B Hoepken
1 reference
T Arledge
1 reference
D van der Heijde
1 reference
13 August 2013
1 reference
1 reference
48-55
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference